With the analysis among 3,057 patents, we discovered top 441 key players by total patent application. Immatics Biotechnologies GmbH, Human Genome Sciences, Inc., AbbVie Biotechnology Ltd. are dominant in this area. They take 26.46% of the total patent filing.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 529
Human Genome Sciences, Inc.
AbbVie Biotechnology Ltd.
F. Hoffmann-La Roche Ltd.
Pennsylvania, United States
Patent: 76
Incyte Pharmaceuticals, Inc.
California, United States
Patent: 57
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 49
Washington, United States
Patent: 48
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 38
Aveo Oncology Pharmaceuticals
Massachusetts, United States
Patent: 34
With the analysis among 54 patents, we discovered top 4 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Cytoimmune Therapeutics, Inc., Context Therapeutics LLC are active in this area.
Institut National de la Santé et de la Recherche Médicale
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 19
Pennsylvania, United States
Patent: 2
Guangdong Sheng, China
Patent: 1
With the analysis among related 582 patents applied in the last 5 years. We discover 220 most active companies in this area. The fast-growing Immatics Biotechnologies GmbH, Eisai R&D Management Co., Ltd., Regeneron Pharmaceuticals, Inc. take 26.29% of patent filing during this period.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 97
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 36
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 20
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 14
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 10
Taiho Pharmaceutical Co., Ltd.
Basel-Stadt, Switzerland
Patent: 9
Xylonix IP Holdings Pte Ltd
undefined undefined
Patent: 8
With the analysis among related 582 patents in last 5 years, we discover 161 new entrants. Enterome SA, Taiho Pharmaceutical Co., Ltd., Mabwell (Shanghai) Bioscience Co., Ltd. are the most active new entrants in this area.
Taiho Pharmaceutical Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.
Shanghai Shi, China
Patent: 7
Yunnan Sheng, China
Patent: 6
Peking University First Hospital
Beijing Shi, China
Patent: 6
Oregon, United States
Patent: 5
Beijing University of Technology
Beijing Shi, China
Patent: 5
Les Laboratoires Servier SAS
Providence Health & Services - Oregon
Oregon, United States
Patent: 5
Precision Biologics, Inc.
Texas, United States
Patent: 4
With the analysis among 1,065 patents, we discovered top 161 universities and scientific research institutions by total patent application. New York University, The Johns Hopkins University, Texas A&M University are dominant in this area. They take 21.97% of the total patent filing.
New York, United States
Patent: 87
The Johns Hopkins University
Texas, United States
Patent: 45
University of Southern California
California, United States
Patent: 37
North Carolina, United States
Patent: 30
The Scripps Research Institute
California, United States
Patent: 18
ZURICH, Switzerland
Patent: 18
The Second Military Medical University
Shanghai Shi, China
Patent: 15
Guangxi Normal University
Guangxi Zhuangzu Zizhiqu, China
Patent: 15
Shanghai Shi, China
Patent: 11